Actinium Pharmaceuticals reported $56.15M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Actinium Pharmaceuticals USD 56.15M 6.87M Sep/2025
Amgen USD 90.59B 445M Dec/2025
Bioline Rx USD 39.8M 3.47M Sep/2025
Capricor Therapeutics USD 126.44M 7.13M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025